Global Information
회사소개 | 문의 | 비교리스트

세계의 동물용 약품 시장(2020-2026년)

Global Veterinary Drug Market 2020-2026

리서치사 Orion Market Research Pvt Ltd
발행일 2020년 06월 상품 코드 949602
페이지 정보 영문
가격
US $ 3,600 ₩ 4,243,000 Unprintable PDF (Single User License)
US $ 4,800 ₩ 5,658,000 Printable PDF (Enterprise License)


세계의 동물용 약품 시장(2020-2026년) Global Veterinary Drug Market 2020-2026
발행일 : 2020년 06월 페이지 정보 : 영문

세계 동물용 약품 시장에서는 2020-2026년간 연평균 복합 성장률(CAGR) 약 5.5%를 나타낼 것으로 예상됩니다. 애완동물 채용 증가, 사람과 가축 공통 감염증의 가능성 증가, 고기 및 유제품 소비 증가가 세계 시장 성장의 주요인입니다. 또한 기업의 신약 발매 증가, 의약품 온라인 액세스, 동물 건강 인프라 개선은 전세계 시장 성장을 촉진하는 기타 요인 중 하나입니다.

세계의 동물용 약품(Veterinary Drug) 시장을 조사했으며, 시장 개요, 시장 성장요인 및 저해요인 분석, 동물·종류·투여 경로·지역별 시장 규모 추이와 예측, 경쟁 구도, 주요 기업 개요, 시장 기회 등의 정보를 전해드립니다.

목차

제1장 보고서 개요

제2장 시장 개요와 인사이트

  • 조사 범위
  • 애널리스트 인사이트와 현재 시장 동향
  • 규칙과 규제

제3장 경쟁 구도

  • 기업 점유율 분석
  • 주요 전략 분석
  • 주요 기업 분석
    • Zoetis, Inc.
    • Merck & Co., Inc.
    • Boehringer Ingelheim International GmbH
    • Bayer AG
    • Elanco Animal Health Inc.

제4장 시장 결정요인

  • 동기
  • 억제요인
  • 시장 기회

제5장 시장 세분화

  • 동물별
    • 가축
    • 반려동물
    • 기타
  • 유형별
    • 반기생성
    • 항염증약
    • 항감염약
    • 기타
  • 투여 경로별
    • 경구
    • 국소
    • 주사
    • 기타

제6장 지역 분석

  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 이탈리아
    • 스페인
    • 프랑스
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 기타 아시아태평양
  • 기타 지역

제7장 기업 개요

  • Akorn Animal Health, Inc.
  • Bayer AG
  • Bimeda Holdings PLC
  • Biogenesis Bago A.S.
  • BOEHRINGER Ingelheim International GmbH
  • Ceva Sante Animale
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Inc.
  • Hipra S.A.
  • Huvepharma EOOD
  • Hygieia Biological Laboratories
  • Intervet International B.V
  • Merck & Co., Inc.
  • Neogen Corp.
  • Pharmgate LLC
  • Phibro Animal Health Corp.
  • Vetoquinol S.A.
  • Virbac S.A.
  • Zoetis, Inc.
LSH 20.08.12

LIST OF TABLES

  • 1. GLOBAL VETERINARY DRUG MARKET RESEARCH AND ANALYSIS BY ANIMAL, 2019-2026 ($ MILLION)
  • 2. GLOBAL LIVESTOCK DRUG MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 3. GLOBAL POULTRY DRUG MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 4. GLOBAL ANIMAL DRUG MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 5. GLOBAL CATTLE DRUG MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 6. GLOBAL AQUATIC DRUG MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 7. GLOBAL OTHERS LIVESTOCK ANIMAL DRUG MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 8. GLOBAL COMPANION ANIMAL DRUG MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 9. GLOBAL OTHER ANIMAL DRUG MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 10. GLOBAL VETERINARY DRUG MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 11. GLOBAL ANTI-PARASITIC DRUG MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 12. GLOBAL ANTI-INFLAMMATORY DRUG MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 13. GLOBAL ANTI-INFECTIVE DRUG MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 14. GLOBAL OTHERS DRUG MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 15. GLOBAL VETERINARY DRUG MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
  • 16. GLOBAL ORAL ROUTE OF ADMINISTRATION MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 17. GLOBAL TOPICAL ROUTE OF ADMINISTRATION MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 18. GLOBAL INJECTION ROUTE OF ADMINISTRATION MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 19. GLOBAL OTHER ROUTE OF ADMINISTRATION MARKET RESEARCH AND ANALYSIS, 2019-2026 ($ MILLION)
  • 20. NORTH AMERICAN VETERINARY DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 21. NORTH AMERICAN VETERINARY DRUG MARKET RESEARCH AND ANALYSIS BY ANIMAL, 2019-2026 ($ MILLION)
  • 22. NORTH AMERICAN VETERINARY DRUG MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 23. NORTH AMERICAN VETERINARY DRUG MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
  • 24. EUROPEAN VETERINARY DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 25. EUROPEAN VETERINARY DRUG MARKET RESEARCH AND ANALYSIS BY ANIMAL, 2019-2026 ($ MILLION)
  • 26. EUROPEAN VETERINARY DRUG MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 27. EUROPEAN VETERINARY DRUG MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
  • 28. ASIA PACIFIC VETERINARY DRUG MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2019-2026 ($ MILLION)
  • 29. ASIA PACIFIC VETERINARY DRUG MARKET RESEARCH AND ANALYSIS BY ANIMAL, 2019-2026 ($ MILLION)
  • 30. ASIA PACIFIC VETERINARY DRUG MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 31. ASIA PACIFIC VETERINARY DRUG MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)
  • 32. REST OF THE WORLD VETERINARY DRUG MARKET RESEARCH AND ANALYSIS BY ANIMAL, 2019-2026 ($ MILLION)
  • 33. REST OF THE WORLD VETERINARY DRUG MARKET RESEARCH AND ANALYSIS BY TYPE, 2019-2026 ($ MILLION)
  • 34. REST OF THE WORLD VETERINARY DRUG MARKET RESEARCH AND ANALYSIS BY ROUTE OF ADMINISTRATION, 2019-2026 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL VETERINARY DRUG MARKET SHARE BY ANIMAL, 2019 VS 2026 (%)
  • 2. GLOBAL VETERINARY DRUG MARKET SHARE BY TYPE, 2019 VS 2026 (%)
  • 3. GLOBAL VETERINARY DRUG MARKET SHARE BY ROUTE OF ADMINISTRATION, 2019 VS 2026 (%)
  • 4. GLOBAL VETERINARY DRUG MARKET SHARE BY GEOGRAPHY, 2019 VS 2026 (%)
  • 5. US VETERINARY DRUG MARKET SIZE, 2019-2026 ($ MILLION)
  • 6. CANADA VETERINARY DRUG MARKET SIZE, 2019-2026 ($ MILLION)
  • 7. UK VETERINARY DRUG MARKET SIZE, 2019-2026 ($ MILLION)
  • 8. FRANCE VETERINARY DRUG MARKET SIZE, 2019-2026 ($ MILLION)
  • 9. GERMANY VETERINARY DRUG MARKET SIZE, 2019-2026 ($ MILLION)
  • 10. ITALY VETERINARY DRUG MARKET SIZE, 2019-2026 ($ MILLION)
  • 11. SPAIN VETERINARY DRUG MARKET SIZE, 2019-2026 ($ MILLION)
  • 12. REST OF EUROPE VETERINARY DRUG MARKET SIZE, 2019-2026 ($ MILLION)
  • 13. INDIA VETERINARY DRUG MARKET SIZE, 2019-2026 ($ MILLION)
  • 14. CHINA VETERINARY DRUG MARKET SIZE, 2019-2026 ($ MILLION)
  • 15. JAPAN VETERINARY DRUG MARKET SIZE, 2019-2026 ($ MILLION)
  • 16. REST OF ASIA-PACIFIC VETERINARY DRUG MARKET SIZE, 2019-2026 ($ MILLION)

Global Veterinary Drug Market Size, Share & Trends Analysis Report, By Animal (Livestock, Companion, Other), By Type (Anti-Parasitic, Anti-inflammatory, Anti-infective, Others), By Route of Administration (Oral, Injection, Topical, Other) and Forecast, 2020-2026

The veterinary drug market is expected to witness a CAGR of around 5.5% during the forecast period 2020-2026. Increasing the adoption of pet animals, the growing possibility of zoonotic diseases and growth in meat and dairy consumption are the key factors for the growth of the market globally. Besides, growth in new drug launch by the companies, online access to the drugs, improvement in the health infrastructure for animals is some of the other factors driving the growth of the market all across the globe.

The global veterinary drug market is divided on the basis of animal, type, and route of administration. By animal, the market is further divided into livestock, companion, other. During the forecast period, companion animals are expected to have a major market share owing to better facilities reach to them provided by their owners. On the basis of type, the market is further divided into anti-parasitic, anti-inflammatory, anti-infective, and others. By route of administration, the market is divided into oral, injection, and topical. Oral route holds a significant market share in the market

The veterinary drug market is also studied by geography and is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). During the forecast period, North America is expected to hold a major market share. Moreover, a lucrative growth is expected in Asia-Pacific due to rising pet ownership, and increasing veterinary healthcare infrastructure in emerging economies.

The veterinary drug market is a fragmented market however a large market is occupied by a few companies. Some of the key players in the market include Zoetis, Inc., Bayer AG, BOEHRINGER Ingelheim International GmbH, Ceva Sante Animale, Merck & Co., Inc., Elanco Animal Health Inc., Vetoquinol S.A., and Virbac S.A. These companies are adopting growth strategies including mergers and acquisitions, product launches, and partnerships & collaborations to gain a competitive edge in the market.

Research Methodology

The market study of the global veterinary drug market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to breakdown the market in various segments; derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts to amplify the added validity of our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market
  • Authentic public databases
  • Whitepapers, research-papers, and news blogs
  • Company websites and their product catalog

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

  • Global Veterinary Drug Market Research and Analysis, By Animal
  • Global Veterinary Drug Market Research and Analysis, By Type
  • Global Veterinary Drug Market Research and Analysis, By Route of Administration

The Report Covers:

  • Comprehensive research methodology of the Global Veterinary Drug Market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global Veterinary drug Market.
  • Insights about market determinants which are stimulating the Global Veterinary Drug Market.
  • Detailed and extensive market segments with regional distribution of forecast revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdowns
    • 1.2.1. By Segments
    • 1.2.2. By Geography

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion
  • 2.3. Rules & Regulations

3. Competitive Landscape

  • 3.1. Company Share Analysis
  • 3.2. Key Strategy Analysis
  • 3.3. Key Company Analysis
    • 3.3.1. Zoetis, Inc.
      • 3.3.1.1. Overview
      • 3.3.1.2. Financial Analysis
      • 3.3.1.3. SWOT Analysis
      • 3.3.1.4. Recent Developments
    • 3.3.2. Merck & Co., Inc.
      • 3.3.2.1. Overview
      • 3.3.2.2. Financial Analysis
      • 3.3.2.3. SWOT Analysis
      • 3.3.2.4. Recent Developments
    • 3.3.3. Boehringer Ingelheim International GmbH
      • 3.3.3.1. Overview
      • 3.3.3.2. Financial Analysis
      • 3.3.3.3. SWOT Analysis
      • 3.3.3.4. Recent Developments
    • 3.3.4. Bayer AG
      • 3.3.4.1. Overview
      • 3.3.4.2. Financial Analysis
      • 3.3.4.3. SWOT Analysis
      • 3.3.4.4. Recent Developments
    • 3.3.5. Elanco Animal Health Inc.
      • 3.3.5.1. Overview
      • 3.3.5.2. Financial Analysis
      • 3.3.5.3. SWOT Analysis
      • 3.3.5.4. Recent Developments

4. Market Determinants

  • 4.1 Motivators
  • 4.2 Restraints
  • 4.3 Opportunities

5. Market Segmentation

  • 5.1. Global Veterinary Drug Market by Animal
    • 5.1.1. Livestock
      • 5.1.1.1. Poultry
      • 5.1.1.2. Swine
      • 5.1.1.3. Cattle
      • 5.1.1.4. Aquatic
      • 5.1.1.5. Others (Sheep)
    • 5.1.2. Companion
    • 5.1.3. Other
  • 5.2. Global Veterinary Drug Market by Type
    • 5.2.1. Anti-Parasitic
    • 5.2.2. Anti-inflammatory
    • 5.2.3. Anti-infective
    • 5.2.4. Others
  • 5.3. Global Veterinary Drug Market by Route of Administration
    • 5.3.1. Oral
    • 5.3.2. Topical
    • 5.3.3. Injection
    • 5.3.4. Other

6. Regional Analysis

  • 6.1. North America
    • 6.1.1. United States
    • 6.1.2. Canada
  • 6.2. Europe
    • 6.2.1. UK
    • 6.2.2. Germany
    • 6.2.3. Italy
    • 6.2.4. Spain
    • 6.2.5. France
    • 6.2.6. Rest of Europe
  • 6.3. Asia-Pacific
    • 6.3.1. China
    • 6.3.2. India
    • 6.3.3. Japan
    • 6.3.4. Rest of Asia-Pacific
  • 6.4. Rest of the World

7. Company Profiles

  • 7.1. Akorn Animal Health, Inc.
  • 7.2. Bayer AG
  • 7.3. Bimeda Holdings PLC
  • 7.4. Biogenesis Bago A.S.
  • 7.5. BOEHRINGER Ingelheim International GmbH
  • 7.6. Ceva Sante Animale
  • 7.7. Dechra Pharmaceuticals PLC
  • 7.8. Elanco Animal Health Inc.
  • 7.9. Hipra S.A.
  • 7.10. Huvepharma EOOD
  • 7.11. Hygieia Biological Laboratories
  • 7.12. Intervet International B.V
  • 7.13. Merck & Co., Inc.
  • 7.14. Neogen Corp.
  • 7.15. Pharmgate LLC
  • 7.16. Phibro Animal Health Corp.
  • 7.17. Vetoquinol S.A.
  • 7.18. Virbac S.A.
  • 7.19. Zoetis, Inc.
Back to Top
전화 문의
F A Q